Moreover, TRPA1 can be activated by oxidative stress and glucose metabolism by-products, such as 4-hydroxy-2-nonenal (4-HNE) and methylglyoxal, which are elevated in diabetes, contributing to hyperalgesia (Trevisani et al., 2007). Here, TRPA1 is linked to diabetes mellitus.